Expert Advocates Universal Genetic Testing in Breast Cancer

Andrew D. Smith
Published: Monday, Aug 05, 2019
Pat W. Whitworth, MD

Pat W. Whitworth, MD

Although research findings have established many applications for genetic information in breast cancer, not enough patients are being tested for the risk of germline mutations and new strategies are needed to broaden the clinical application of genomic advancements, according to experts in the field.


Figure. Gene Mutations in a Breast Cancer Population2


Table. Guideline Definition of Patients Testing Positive2

TABLE. GUIDELINE DEFINITION OF PATIENTS TESTING POSITIVE2 Whitworth, a breast cancer surgeon at Saint Thomas Health in Nashville, Tennessee, is among those advocating for change. The failure to screen sufficiently for potentially deleterious BRCA mutations stems from systemic problems, Whitworth maintained during a presentation at the 36th Annual Miami Breast Cancer Conference® (MBCC).3
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication